Imprinting: DNA Methyltransferases Illuminate Reprogramming
Progress in studying epigenetic reprogramming in plants has been impeded by the difficulty in obtaining tissue for analysis. Now, using a combination of fluorescent reporters and translational fusions, a new study sheds some light on this process.
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The importance of chromatin modification has been well established in the context of gene regulation and transposon repression. Histone tail modifications and DNA methylation are two major hallmarks of epigenetic regulation, and both have an intricate relationship with small RNA biogenesis and function [1] . Whereas epigenetic changes in somatic cells can have important consequences on an individual, similar modifications in the germline can affect multiple individuals throughout many generations.
The epigenetic marks defined during development must be reset in the germline in order for the zygote to acquire pluripotency and subsequently to initiate embryonic development. This principle is clearly illustrated in mammals, where DNA methylation marks are reset once during sperm maturation, and again during early embryo development [2, 3] . Comparably less is known about resetting epigenetic marks during plant development, where different types of DNA methylation might reflect different aspects of transposon and gene regulation. These different types of methylation can be classified based on the context of the methylated cytosine (CG, CHG and CHH methylation, where H represents any residue other than G). The work by Jullien et al. [4] published recently in Current Biology provides more insights into the process of DNA methylation-dependent reprogramming through embryo development. The authors combine the use of fluorescent reporters and bisulfite sequencing on a number of loci in the developing embryo to show a progressive increase in DNA methylation through embryogenesis, specifically in the CHH context. They are also able to show a correlation, through the use of fluorescent translational fusions, between the expression of DNA methyltransfereases and the observed methylation landscape.
Symmetric CG DNA methylation is maintained in a replication-dependent manner, during which a hemi-methylated parent strand is used as a template to direct methylation on the daughter strand. DNA METHYLTRANSFERASE 1 (MET1), the plant homolog of Dmnt1, performs this process. Furthermore, CHROMOMETHYLASE 3 (CMT3), a plant-specific methyltransferase, performs CHG methylation in a mechanism intertwined with lysine 9 methylation of the tail on histone H3 [5] . Though these are the proteins principally involved in symmetric DNA methylation, there are some other homologous genes that participate in this process and are redundant with one another (specifically, MET2, MET3, CMT1, CMT2). This redundancy provides an additional challenge to the elucidation of the complete methylation mechanism. Additionally, plants have another type of DNA methylation, not as prevalent as the symmetric methylation described above, which is replication-independent, and relies on RNA-directed DNA methylation (RdDM). The DNA methyltransferase DOMAINS REARRANGED METHYLASE 2 (DRM2; and its less ubiquitous homolog DRM1) are required for this process, as well as specific RNA polymerase (pol IV and pol V) subunits, NRPD1a, and NRPE1a -both of which are also involved in production and utilization of 24nt siRNA [6] . Although the elucidation of these mechanisms has greatly increased our current understanding of this type of methylation, many questions still remain.
Fluorescent DNA methyltransferase DRM1 and DRM2 reporter lines have revealed specific expression of DRM1 in the egg cell and increased expression of DRM2 in the egg cell and developing embryo. Insertional mutants for DRM1 show no obvious defect; however, its specific expression in the egg cell, as reported by Jullien et al. [4] , suggests a particular role for DRM1 at a discrete stage in germline development, which would be an interesting avenue for future studies. The authors also previously showed the absence of maintenance DNA methyltransferases in the egg cell and the absence of both maintenance and de novo methyltransferases in the central cell [7] . This finding is in accordance with the current view that DNA methylation levels are dramatically reduced in the endosperm. The situation is much different in the developing embryo, however, where the expression of methyltransferases dramatically increases. Now, the new results of Jullien et al. [4] point to a very important role for RdDM in de novo CG, CHG and CHH methylation in the embryo.
The difficulty in isolating the different cells of the female gametophyte has resulted in an incomplete view of the methylation landscape throughout its development, especially in the egg cell. In contrast, the male germline is more readily accessible to tissue collection, and has therefore provided us with major insights regarding epigenetic marks prior to fertilization [8] [9] [10] . Studies here indicate that both CG and CHG methylation are maintained in sperm cells, while CHH methylation is greatly reduced. These observations are in accordance with the observations presented by Jullien et al. [4] , as CG and CHG methylation appears quite steady through embryo development, while CHH methylation is progressively re-established in accordance with DRM2 expression. The only reported reduction of methylation during female gametogenesis and embryogensis is a loss of CG methytlation observed in the central cell and subsequently in the endosperm, mediated by the repression of MET1 [11, 12] and the activation of DME [13] . The results are still some what unclear, as methyltransferases seem to be downregulated in the egg cell even though symmetric methylation, at least in the CG context, appears to be quite high even in the early embryo. Advances in tissue isolation techniques will undoubtedly address the lack of female methylation data, and, perhaps -in combination with third-generation sequencing technology -will even provide us with new insights into the methylation landscape at the single-cell level [14] .
One of the most striking observations made by Jullien et al. [4] is that asymmetric CHH methylation is re-established throughout embryogenesis ( Figure 1 ) and provides the foundation for further mechanistic study into how this occurs. Analysis of pol IV and pol V expression profiles, as well as sequencing of 24nt small RNAs in the egg cell and embryo would provide major insight into this process. A previous study [15] reported a very low abundance of 24nt small RNAs produced by pol IV in the embryo, in contrast to the endosperm and seed coat, where much higher levels of these small RNAs were detected [15] . Moreover, these siRNAs, when examined in light of ecotype-specific crosses, proved to be maternal in origin. This result suggests that either these small RNAs move from the neighboring tissue types, or that they were under the detection limit in the embryo at the time stage they examined. These observations are made all the more interesting in light of the DNA methylation and methyltransferase expression data presented by Jullien et al. [4] .
The use of translational fusions, utilized here for DNA methyltransferases, proved to be very informative and should be extended to other components of the RdDM pathway. This study would be particularly interesting for NRPDa/b (subunits of pol IV) to assess in which part of the ovule the biogenesis of the 24nt small RNAs required to direct CHH methylation occurs. If biogenesis of these small RNAs occurs in the endosperm instead of or in addition to the embryo itself, this would imply movement of a specific class of small RNA in the female gametophyte, reminiscent of the proposed movement of small RNA in pollen [8] . Speaking of pollen, pol IV reporter lines would also allow us to determine whether pol IV is expressed in the sperm cells, opening up the possibility that both male and female gametophytic cells contribute 24nt small RNAs to the developing embryo.
Even broader implications can be drawn from the important finding of DNA methylation re-establishment in the embryo with regards to the transmission of 'epialleles', which are genetically identical genes that differ only in their covalent chromatin modifications [4] . Two recent studies provide additional genome-wide DNA methylation profiling data over multiple generations and uncover a number of epialleles. These studies uncovered fluctuations in the methylation landscape and expression of the epialleles based on different levels of methylation over multiple generations. The origins of this fluctuation, however, are unclear and it is proposed that the gains and losses in methylation might be pre-programmed in the germline [16, 17] . The reduction and re-establishment of asymmetric methylation during gamete development and early embryogenesis, respectively, could represent a specific pathway for the erasure or establishment of repressive marks on epialleles. These epigenetic marks could perhaps be influenced by external factors such as abiotic stress or genome clashes as a result of interspecies hybridization. This intricate response mechanism relying on RdDM could provide plants a certain flexibility to adapt to both internal and external stresses.
The observations made by Jullien et al. [4] provide the necessary frame work to address the important questions of epigenetic A graphical representation of DNA methylation levels as the embryo develops as seen in Jullien et al. [4] CG (red) and CHG (blue) levels appear relatively constant over the few loci examined, while CHH methylation (green) appears to progressively increase methylation from the early/late globular stage to the heart and green torpedo stages.
